Episode 239: Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

1. Discuss the potential benefits, limitations, and controversies associated with prostate cancer screening.

2. Summarize the key recommendations provided in the AUA/SUO Guideline regarding early detection strategies for prostate cancer.

3. Analyze the implications of the AUA/SUO Guideline on clinical practice, shared decision-making, and patient counseling regarding early detection of prostate cancer.


ACKNOWLEDGEMENTS:

Support provided by independent educational grants from:

Astellas and Pfizer

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Lantheus Medical Imaging

Merck & Co., Inc.